Ferran Nadeu
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 30
- Genetics 27
- Chronic Lymphocytic Leukemia Research 27
- Co-authors
- Elı́as Campo (47 shared papers)Julio Delgado (20 shared papers)Xosé S. Puente (10 shared papers)Dolors Colomer (9 shared papers)Blanca González‐Farré (7 shared papers)Ander Díaz‐Navarro (4 shared papers)Carlos López-Otı́n (2 shared papers)Itziar Salaverría (8 shared papers)
- Journals
- Blood (10 papers)Leukemia (5 papers)HemaSphere (3 papers)Clinical Cancer Research (2 papers)Scientific Reports (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Ferran Nadeu
50 papers receiving 915 citations
Peers
Comparison fields: 5 of 46
- Genetics 352
- Pathology and Forensic Medicine 485
- Cancer Research 185
- Oncology 332
- Immunology 160
Countries citing papers authored by Ferran Nadeu
This map shows the geographic impact of Ferran Nadeu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferran Nadeu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferran Nadeu more than expected).
Fields of papers citing papers by Ferran Nadeu
This network shows the impact of papers produced by Ferran Nadeu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferran Nadeu. The network helps show where Ferran Nadeu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferran Nadeu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 120 | |
| 2 | 2019 | 99 | |
| 3 | 2019 | 68 | |
| 4 | 2020 | 58 | |
| 5 | 2017 | 58 | |
| 6 | 2020 | 47 | |
| 7 | 2018 | 47 | |
| 8 | 2018 | 44 | |
| 9 | 2018 | 44 | |
| 10 | 2015 | 34 | |
| 11 | 2021 | 32 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 22 | |
| 14 | 2022 | 20 | |
| 15 | 2021 | 19 | |
| 16 | 2023 | 17 | |
| 17 | 2021 | 17 | |
| 18 | 2020 | 15 | |
| 19 | 2020 | 13 | |
| 20 | 2020 | 11 |
About Ferran Nadeu
Ferran Nadeu is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Molecular Biology and Immunology, having authored 52 papers that have together received 925 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (27 papers), Viral-associated cancers and disorders (13 papers), Cancer Genomics and Diagnostics (9 papers), Glycosylation and Glycoproteins Research (7 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Genetics (352 citations), Pathology and Forensic Medicine (485 citations), Cancer Research (185 citations), Oncology (332 citations) and Immunology (160 citations). Ferran Nadeu has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Elı́as Campo, Julio Delgado, Xosé S. Puente, Dolors Colomer, Blanca González‐Farré, Ander Díaz‐Navarro, Carlos López-Otı́n, Itziar Salaverría, Armando López‐Guillermo and Eva Giné. Their work appears in journals such as Blood, Leukemia, HemaSphere, Clinical Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.